Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01301235 · ClinicalTrials.gov registry record
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 8
- Enrollment target
NCT01301235: Completed study, sponsored by Massachusetts General Hospital.
NCT01301235 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01301235 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
This is a developmental protocol to determine the MRI based 31P-MRS changes seen in subjects with mitochondrial myopathy using our dynamic exercise protocol and to identify the ideal variable(s) to represent mitochondrial function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01301235
The ClinicalTrials.gov registry entry for NCT01301235 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01301235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01301235 about?
NCT01301235 is a clinical study titled "Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy". This is a developmental protocol to determine the MRI based 31P-MRS changes seen in subjects with mitochondrial myopathy using our dynamic exercise protocol and to identify the ideal variable(s) to represent mitochondrial function.
What is the current status of trial NCT01301235?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2011-02. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT01301235?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.